CCL5 is synthesized and secreted by glioma-associated microglia [119], and thus a CCL5-mediated activation of NF-κB in GSCs may contribute to EC trans-differentiation in GBM, as is the case in other cells. This evidence concerns the gene CCL5 and central nervous system cancer.